Literature DB >> 18561686

Relationship between %dd(10)x and stopping-power ratios for flattening filter free accelerators: a Monte Carlo study.

Guoming Xiong1, D W O Rogers.   

Abstract

The relationship between the photon beam quality specifier %dd(10)x and the Spencer-Attix water water to air restricted mass collision stopping-power ratio, (L/rho))air(water), is studied using Monte Carlo simulation with realistic beams in contrast to the previously used realistic but uniform spectra from an isotropic point source. The differences between accelerators with and without flattening filters are investigated since flattening filter free accelerators appear to be useful for IMRT. Our results show that the standard relationship between %dd(10)x and (L/rho)air(water), which is used in the TG-51 protocol to calculate the quality conversion factor kQ, is acceptable for beams with or without a flattening filter with a maximum error of 0.4%, although a fit to the new data would reduce the maximum error to 0.2%. Reasons for differences between the individual values of %dd(10)x and (L/ rho)air(water) with and without a flattening filter are studied. Specifically the differences due to the softening of the beam, the change in shape of the profile, and the inclusion of radial variations in the photon energy spectra, are investigated. It is shown that if TPR10(20) is used as a beam quality specifier, there are two different relationships between TPR10(20) and (L/rho)air(water) which differ by 0.4%-1%. When using TPR10(20) as a beam quality specifier in a beam without a flattening filter, one should subtract 0.5% from the value of kQ for a given value of TPR10(20).

Entities:  

Mesh:

Year:  2008        PMID: 18561686     DOI: 10.1118/1.2905028

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

1.  Addendum to the AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon beams.

Authors:  Malcolm McEwen; Larry DeWerd; Geoffrey Ibbott; David Followill; David W O Rogers; Stephen Seltzer; Jan Seuntjens
Journal:  Med Phys       Date:  2014-04       Impact factor: 4.071

2.  Direct megavoltage photon calibration service in Australia.

Authors:  D J Butler; G Ramanathan; C Oliver; A Cole; J Lye; P D Harty; T Wright; D V Webb; D S Followill
Journal:  Australas Phys Eng Sci Med       Date:  2014-08-22       Impact factor: 1.430

3.  Survey on utilization of flattening filter-free photon beams in Japan.

Authors:  Takumi Kodama; Keisuke Yasui; Shie Nishioka; Kazunori Miyaura; Toru Takakura; Tetsurou Katayose; Mitsuhiro Nakamura
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

4.  Dosimetric properties of a beam quality-matched 6 MV unflattened photon beam.

Authors:  Yunfei Huang; R Alfredo Siochi; John E Bayouth
Journal:  J Appl Clin Med Phys       Date:  2012-07-05       Impact factor: 2.102

5.  Pinnacle3 modeling and end-to-end dosimetric testing of a Versa HD linear accelerator with the Agility head and flattening filter-free modes.

Authors:  Daniel L Saenz; Ganesh Narayanasamy; Wilbert Cruz; Nikos Papanikolaou; Sotirios Stathakis
Journal:  J Appl Clin Med Phys       Date:  2016-01-08       Impact factor: 2.102

6.  Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group.

Authors:  Ying Xiao; Stephen F Kry; Richard Popple; Ellen Yorke; Niko Papanikolaou; Sotirios Stathakis; Ping Xia; Saiful Huq; John Bayouth; James Galvin; Fang-Fang Yin
Journal:  J Appl Clin Med Phys       Date:  2015-05-08       Impact factor: 2.102

7.  A dosimetric evaluation of flattening filter-free volumetric modulated arc therapy in nasopharyngeal carcinoma.

Authors:  Guishan Fu; Minghui Li; Yixin Song; Jianrong Dai
Journal:  J Med Phys       Date:  2014-07

8.  Choice of a Suitable Dosimeter for Photon Percentage Depth Dose Measurements in Flattening Filter-Free Beams.

Authors:  Silvia Vargas Castrillón; Francisco Cutanda Henríquez
Journal:  J Med Phys       Date:  2017 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.